Filip Dubovsky

Insider Reports History

Entity
Individual
Location
C/O Novavax Inc., 21 Firstfield Road, Gaithersburg, MD
Signature
/s/Mark J. Casey, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Filip Dubovsky:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NOVAVAX INC President, R&D Common Stock 66.6K $969K $14.54 Jun 17, 2024 Direct
NOVAVAX INC President, R&D Stock Option (Right to Buy) 37.5K $228K $6.09 Jun 17, 2024 Direct
NOVAVAX INC President, R&D Restricted Stock Units 5.38K $29.3K $5.45 Mar 10, 2024 Direct

Insider Reports Filed by Filip Dubovsky

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NVAX NOVAVAX INC Jun 17, 2024 6 -$201K 4 Jun 20, 2024 President, R&D
NVAX NOVAVAX INC May 14, 2024 3 -$521K 4 May 15, 2024 President, R&D
NVAX NOVAVAX INC Mar 10, 2024 3 -$14.2K 4 Mar 12, 2024 President, R&D
NVAX NOVAVAX INC Mar 7, 2024 3 -$52.7K 4 Mar 11, 2024 President, R&D
NVAX NOVAVAX INC Mar 1, 2024 1 $0 4 Mar 26, 2024 President, R&D
NVAX NOVAVAX INC Dec 14, 2023 3 $8.34K 4 Dec 18, 2023 President, R&D
NVAX NOVAVAX INC Nov 5, 2023 3 $5.1K 4 Nov 7, 2023 President, R&D
NVAX NOVAVAX INC Sep 16, 2023 3 $50.4K 4 Sep 19, 2023 President, R&D
NVAX NOVAVAX INC Jun 16, 2023 3 $17.3K 4 Jun 21, 2023 President, R&D
NVAX NOVAVAX INC Jun 16, 2023 0 $0 3 Jun 21, 2023 President, R&D